NCT02135419 2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3 Completed
Clinical Trials
7 trialsNCT03499795 2023-07-14
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2
Inovio Pharmaceuticals
Phase 2 Completed
NCT01164722 2020-08-04
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
AIDS Malignancy Consortium
Phase 3 Completed
NCT03202992 2019-02-07
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Completed
NCT00550589 2015-12-21
Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
AIDS Malignancy Consortium
Phase 2 Completed
NCT00066430 2014-09-17
Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
AIDS Malignancy Consortium
Phase 1 Completed
NCT00501306 2011-06-23
Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men
Laser Surgery Care
Completed